Prognostic potential of KLOTHO and SFRP1 promoter methylation in head and neck squamous cell carcinoma-Reference-Cited by-同舟云学术

Prognostic potential of KLOTHO and SFRP1 promoter methylation in head and neck squamous cell carcinoma

Published:2017-08-16 Issue:4 Volume:58 Page:459-465
ISSN:1234-1983
Container-title:Journal of Applied Genetics
language:en
Short-container-title:J Appl Genetics

Author:

Alsofyani Abeer A.,Alsiary Rawiah A.,Samkari Alaa,Alhaj-Hussain Baraa T.,Khan Jalaluddin Azam,Al-Maghrabi Jaudah,Elaimi Aisha,Al-Qahtani Mohammed H.,Abuzenadah Adel M.,Dallol Ashraf^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Genetics,General Medicine

Link

http://link.springer.com/article/10.1007/s13353-017-0404-7/fulltext.html

Reference39 articles.

1. Cai F, Xiao X, Niu X, Shi H, Zhong Y (2016) Aberrant Methylation of MGMT promoter in HNSCC: a meta-analysis. PLoS One 11:e0163534. doi: 10.1371/journal.pone.0163534

2. Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP (2005) Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 114:806–816. doi: 10.1002/ijc.20740

3. Czerninski R, Krichevsky S, Ashhab Y, Gazit D, Patel V, Ben-Yehuda D (2009) Promoter hypermethylation of mismatch repair genes, hMLH1 and hMSH2 in oral squamous cell carcinoma. Oral Dis 15:206–213. doi: 10.1111/j.1601-0825.2008.01510.x

4. Dallol A, Al-Ali W, Al-Shaibani A, Al-Mulla F (2011) Analysis of DNA methylation in FFPE tissues using the MethyLight technology. Methods Mol Biol 724:191–204. doi: 10.1007/978-1-61779-055-3_13

5. Dallol A et al (2012) Methylation of the polycomb group target genes is a possible biomarker for favorable prognosis in colorectal cancer cancer epidemiology, biomarkers & prevention. Oncology 21:2069–2075. doi: 10.1158/1055-9965.epi-12-0755

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetic and Genetics Factors;Molecular Targets and Cancer Therapeutics (Part 1);2023-04-18

2. Identification and Validation of Potentially Clinically Relevant CpG Regions within the Class 2 Tumor Suppressor Gene SFRP1 in Pancreatic Cancer;Cancers;2023-01-22

3. Role of Fibroblast Growth Factor 23 (FGF23) and αKlotho in Cancer;Frontiers in Cell and Developmental Biology;2021-01-14

4. Klotho—open questions, controversies, and future perspectives;Fibroblast Growth Factor 23;2021

5. Epigenetic Modifications in Head and Neck Cancer;Biochemical Genetics;2019-11-11